AsterDex announced on August 19, 2026, the addition of Moderna Inc to its Real World Asset perpetual futures lineup, with the MRNAUSDT trading pair going live on the platform’s pro futures interface.
The listing carries a maximum leverage of 5x and is denominated against USDT. It falls under AsterDex’s RWA perpetual category, which provides synthetic price exposure to real-world equities without requiring traders to hold the underlying stock.
Moderna Inc, traded under the ticker MRNA, is a biotechnology company operating in the mRNA technology sector. Through this perpetual futures contract, traders can take positions tied to MRNA’s price movements directly within the AsterDex ecosystem.
The MRNAUSDT pair is accessible on the AsterDex pro futures platform as of the announcement date. Traders can access the market directly at Trade on AsterDex.
This listing adds a biotechnology sector asset to AsterDex’s growing RWA perpetual product suite, expanding the range of equity-linked instruments available to users on the platform.
Source: Asterdex · Published by CoinsProbe Markets Desk
The opinions and market insights shared on CoinsProbe represent the views of individual authors based on prevailing market conditions at the time of publication. Cryptocurrency investments carry significant risk and volatility. Readers are encouraged to conduct their own research and seek professional financial advice before making investment decisions. CoinsProbe and its contributors do not accept responsibility for financial losses or decisions made based on published content.
CoinsProbe may publish sponsored articles, affiliate links, or promotional collaborations. All sponsored material is clearly labeled to maintain transparency with our audience. Our editorial decisions remain fully independent, and advertising partnerships do not influence reviews, rankings, or published opinions.
Since 2023, CoinsProbe has delivered reliable insights on cryptocurrency, blockchain, and digital assets. Our content is created by experienced researchers and analysts who follow strict editorial standards focused on accuracy, transparency, and credibility. Every article is carefully reviewed and verified using trusted sources and current market data. We provide unbiased analysis and timely updates covering everything from emerging crypto projects to major industry developments.
